This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,677.52 firm fixed-price delivery order is for the supply of ENVARSUS XR 1 MG TABLET 100S, a specialty pharmaceutical product. The contract has an ultimate completion date of January 3, 2025.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is a call against that larger IDC. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's federal contract portfolio demonstrates its critical role in supplying a wide array of medical commodities, including specialty medications, generic drugs, medical devices, and other essential products to federal agencies, particularly the DLA and Department of Justice.
Generated 3/12/25, 9:59 AM